Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SUCLA2 pseudogene 2 (SUCLA2P2) is a non-protein-coding segment of human DNA located on chromosome 6. It shares sequence similarity with the SUCLA2 gene, which encodes a mitochondrial enzyme subunit involved in the citric acid (TCA) cycle and mitochondrial DNA maintenance[1][5]. Unlike the functional SUCLA2 gene, SUCLA2P2 does not encode a functional protein and has no known enzymatic activity or direct role in metabolism or disease. No drug interactions, biomarker utility, or therapeutic interventions are associated with this pseudogene. Pseudogenes like SUCLA2P2 may have regulatory effects on their protein-coding counterparts, but such roles have not been documented for SUCLA2P2. Additional context: - The functional *SUCLA2* gene (not the pseudogene) has relevance in mitochondrial DNA depletion syndromes and metabolic disorders, but these associations do **not apply** to *SUCLA2P2*[1][5]. - Pseudogenes are often catalogued for reference or genomic study, not therapeutic development. If you need information about the active SUCLA2 gene/protein, clarify the query accordingly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Succinate-CoA ligase ADP-forming beta subunit pseudogene 2 (SUCLA2P2).